54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
00:29 UTC
|
WIX
Wix.com
|
◎ Target | Mark Zgutowicz ★★☆☆☆ #2616 | Buy | $85.00→ $90.00+5.9% |
|
Aug 06
00:29 UTC
|
WIX
Wix.com
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Overweight | $65.00→ $80.00+23.1% |
|
Aug 06
00:29 UTC
|
WIX
Wix.com
|
◎ Target | Alec Brondolo ★★★☆☆ #1228 | Equal Weight | $46.00→ $64.00+39.1% |
|
Aug 06
00:29 UTC
|
WIX
Wix.com
|
◎ Target | Brad Erickson ★★★☆☆ #1954 | Sec→ r Perform | $45.00→ $60.00+33.3% |
|
Aug 06
00:29 UTC
|
WIX
Wix.com
|
◎ Target | Chris Zhang not yet tracked | Neutral | $58.00→ $66.00+13.8% |
|
Aug 06
00:29 UTC
|
WHR
Whirlpool
|
◎ Target | Mike Dahl not yet tracked | Underperform | $30.00→ $32.00+6.7% |
|
Aug 06
00:29 UTC
|
WAT
Waters
|
◎ Target | Evan Stampler not yet tracked | Equal Weight | $370.00→ $400.00+8.1% |
|
Aug 06
00:29 UTC
|
WAT
Waters
|
◎ Target | Dan Leonard ★★★★★ #120 | Outperform | $435.00→ $475.00+9.2% |
|
Aug 06
00:29 UTC
|
WAT
Waters
|
◎ Target | Luke Sergott ★★★★★ #69 | Overweight | $425.00→ $460.00+8.2% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Steven Forbes ★★★★☆ #478 | Buy | $100.00→ $135.00+35.0% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Steven Shemesh ★★★★☆ #788 | Sec→ r Perform | $78.00→ $92.00+17.9% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Michael Lasser ★★★★☆ #683 | Buy | $118.00→ $156.00+32.2% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | John Blackledge ★★★☆☆ #1192 | Hold | $75.00→ $110.00+46.7% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Brian Pitz ★★★☆☆ #1842 | Market Perform | $105.00→ $115.00+9.5% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Zachary Fadem ★★★★☆ #960 | Overweight | $100.00→ $130.00+30.0% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Ygal Arounian ★★★☆☆ #2067 | Neutral | $85.00→ $125.00+47.1% |
|
Aug 06
00:29 UTC
|
W
Wayfair
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $83.00→ $133.00+60.2% |
|
Aug 06
00:29 UTC
|
VSVS
Vesuvius
|
◎ Target | firm only | Buy | GBX 520→ GBX 450-13.5% |
|
Aug 06
00:29 UTC
|
VSAT
Viasat
|
◎ Target | Ryan Koontz ★☆☆☆☆ #3105 | Buy | $90.00→ $105.00+16.7% |
|
Aug 06
00:29 UTC
|
VRTX
Vertex Pharmaceuticals
|
◎ Target | Eliana Merle ★★★☆☆ #1386 | Overweight | $615.00→ $617.00+0.3% |
|
Aug 06
00:29 UTC
|
VRTX
Vertex Pharmaceuticals
|
◎ Target | Danielle Brill ★★★☆☆ #2038 | Buy | $560.00→ $565.00+0.9% |
|
Aug 06
00:29 UTC
|
VNP
5N Plus
|
◎ Target | firm only | Outperform | C$50.00→ C$45.00-10.0% |
|
Aug 06
00:29 UTC
|
VNP
5N Plus
|
◎ Target | firm only | Sec→ r Outperform | C$48.00→ C$35.00-27.1% |
|
Aug 06
00:29 UTC
|
VNP
5N Plus
|
◎ Target | firm only | Buy | C$50.00→ C$45.00-10.0% |
|
Aug 06
00:29 UTC
|
VNOM
Viper Energy
|
◎ Target | firm only | Buy | $58.00→ $59.00+1.7% |
|
Aug 06
00:29 UTC
|
VNO
Vornado Realty Trust
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1105 | Neutral | $42.00→ $44.00+4.8% |
|
Aug 06
00:29 UTC
|
VLRS
Controladora Vuela Compania de Aviacion
|
◎ Target | Alberto Valerio ★★☆☆☆ #2273 | Buy | $9.00→ $11.00+22.2% |
|
Aug 06
00:29 UTC
|
VIK
Viking
|
◎ Target | Trey Bowers ★★★☆☆ #1439 | Overweight | $109.00→ $128.00+17.4% |
|
Aug 06
00:29 UTC
|
VGNT
Versigent
|
◎ Target | Itay Michaeli ★★☆☆☆ #2791 | Buy | $49.00→ $58.00+18.4% |
|
Aug 06
00:29 UTC
|
VGNT
Versigent
|
◎ Target | Colin Langan ★★☆☆☆ #2484 | Overweight | $48.00→ $56.00+16.7% |
|
Aug 06
00:29 UTC
|
UTG
Unite Group
|
◎ Target | firm only | Buy | GBX 623→ GBX 668+7.2% |
|
Aug 06
00:29 UTC
|
URGN
Urogen Pharma
|
◎ Target | Tara Bancroft ★☆☆☆☆ #2985 | Buy | $50.00→ $60.00+20.0% |
|
Aug 06
00:29 UTC
|
UPST
Upstart
|
◎ Target | Kyle Peterson ★★★☆☆ #1696 | Buy | $40.00→ $42.00+5.0% |
|
Aug 06
00:29 UTC
|
UPST
Upstart
|
◎ Target | Patrick Moley ★★★☆☆ #1855 | Overweight | $46.00→ $51.00+10.9% |
|
Aug 06
00:29 UTC
|
ULVR
Unilever
|
◎ Target | firm only | Hold | GBX 5,040→ GBX 5,050+0.2% |
|
Aug 06
00:29 UTC
|
ULS
UL Solutions
|
◎ Target | Joshua Chan ★★★☆☆ #1306 | Buy | $110.00→ $96.00-12.7% |
|
Aug 06
00:29 UTC
|
ULS
UL Solutions
|
◎ Target | Jason Haas not yet tracked | Overweight | $120.00→ $104.00-13.3% |
|
Aug 06
00:29 UTC
|
ULS
UL Solutions
|
◎ Target | Arthur Truslove ★★★★☆ #841 | Neutral | $106.40→ $82.80-22.2% |
|
Aug 06
00:29 UTC
|
UFCS
United Fire Group
|
◎ Target | Paul Newsome ★★★★★ #140 | Overweight | $57.00→ $60.00+5.3% |
|
Aug 06
00:29 UTC
|
TYGO
Tigo Energy
|
◎ Target | Amit Dayal ★☆☆☆☆ #3182 | Buy | $6.00→ $3.50-41.7% |
|
Aug 06
00:29 UTC
|
TWST
Twist Bioscience
|
◎ Target | David Westenberg ★★★★★ #76 | Overweight | $85.00→ $115.00+35.3% |
|
Aug 06
00:29 UTC
|
TVTX
Travere Therapeutics
|
◎ Target | Vamil Divan ★★★★☆ #905 | Buy | $65.00→ $75.00+15.4% |
|
Aug 06
00:29 UTC
|
TVTX
Travere Therapeutics
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2804 | Buy | $70.00→ $85.00+21.4% |
|
Aug 06
00:29 UTC
|
TVTX
Travere Therapeutics
|
◎ Target | Tyler Van Buren ★★☆☆☆ #2612 | Buy | $60.00→ $75.00+25.0% |
|
Aug 06
00:29 UTC
|
TPK
Travis Perkins
|
◎ Target | firm only | Hold | GBX 580→ GBX 650+12.1% |
|
Aug 06
00:29 UTC
|
TPK
Travis Perkins
|
◎ Target | firm only | Sell | GBX 470→ GBX 550+17.0% |
|
Aug 06
00:29 UTC
|
TPG
TPG
|
◎ Target | Benjamin Budish ★★★★☆ #729 | Overweight | $58.00→ $64.00+10.3% |
|
Aug 06
00:29 UTC
|
TPG
TPG
|
◎ Target | Michael Brown ★★★★☆ #466 | Outperform | $53.00→ $57.00+7.5% |
|
Aug 06
00:29 UTC
|
TPG
TPG
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $59.00→ $65.00+10.2% |
|
Aug 06
00:29 UTC
|
TPG
TPG
|
◎ Target | Bart Dziarski ★★★★☆ #823 | Outperform | $60.00→ $65.00+8.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.